Cross-Sector entity

James Head

Person
5

All 1 tracked stories fall under one category: markets. Alignment Healthcare is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Cross-Sector story that mention James Head, all published on March 14, 2026.

1 verified story tracked

Last mentioned: Mar 14, 2026

Entity pulse

Recent coverage · James Head

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about James Head

All 1 tracked stories fall under one category: markets. Alignment Healthcare is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Cross-Sector story that mention James Head, all published on March 14, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering James Head. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Insider Selling

    President and another insider sell a combined 33,157 shares.

  2. Analyst Downgrade

    Wall Street Zen cuts ALHC rating to Hold.

  3. Secondary Offering

    Company prices 13.2M shares at $19.46 to raise capital.

  4. Q4 Earnings Report

    Alignment Healthcare reports declining losses and operational growth.

Stories mentioning James Head 1

Finance markets Neutral 5

Alignment Healthcare Insider Sales Follow $257M Secondary Offering

Alignment Healthcare's President and another insider divested over 33,000 shares in mid-March, following a massive secondary offering and a rating downgrade. The sales come as the Medicare Advantage provider reports narrowing losses but faces a shift in analyst sentiment from 'Buy' to 'Hold.'

2 sources